GR3021925T3 - Method and compositions for inhibiting angiogenesis - Google Patents

Method and compositions for inhibiting angiogenesis

Info

Publication number
GR3021925T3
GR3021925T3 GR960403330T GR960403330T GR3021925T3 GR 3021925 T3 GR3021925 T3 GR 3021925T3 GR 960403330 T GR960403330 T GR 960403330T GR 960403330 T GR960403330 T GR 960403330T GR 3021925 T3 GR3021925 T3 GR 3021925T3
Authority
GR
Greece
Prior art keywords
collagenase
inhibitor
compositions
specific
inhibiting angiogenesis
Prior art date
Application number
GR960403330T
Other languages
English (en)
Inventor
Marsha A Moses
Judith Sudhalter
Original Assignee
Childrens Hosp Medical Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hosp Medical Center filed Critical Childrens Hosp Medical Center
Publication of GR3021925T3 publication Critical patent/GR3021925T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8146—Metalloprotease (E.C. 3.4.24) inhibitors, e.g. tissue inhibitor of metallo proteinase, TIMP
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
GR960403330T 1990-01-25 1996-12-06 Method and compositions for inhibiting angiogenesis GR3021925T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47006790A 1990-01-25 1990-01-25
US59155990A 1990-10-02 1990-10-02
PCT/US1991/000559 WO1991011193A1 (en) 1990-01-25 1991-01-25 Method and compositions for inhibiting angiogenesis

Publications (1)

Publication Number Publication Date
GR3021925T3 true GR3021925T3 (en) 1997-03-31

Family

ID=27042958

Family Applications (1)

Application Number Title Priority Date Filing Date
GR960403330T GR3021925T3 (en) 1990-01-25 1996-12-06 Method and compositions for inhibiting angiogenesis

Country Status (10)

Country Link
EP (1) EP0512071B1 (el)
JP (1) JPH06509791A (el)
AT (1) ATE144710T1 (el)
AU (1) AU652744B2 (el)
CA (1) CA2074725A1 (el)
DE (1) DE69122956T2 (el)
DK (1) DK0512071T3 (el)
ES (1) ES2093699T3 (el)
GR (1) GR3021925T3 (el)
WO (1) WO1991011193A1 (el)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5268384A (en) * 1990-11-21 1993-12-07 Galardy Richard E Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
US5853746A (en) * 1991-01-31 1998-12-29 Robert Francis Shaw Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
DE4106570A1 (de) * 1991-03-01 1992-09-03 Max Planck Gesellschaft Neue inhibitoren der endothelzell-proliferation
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
DE69435342D1 (de) * 1993-07-19 2011-05-05 Angiotech Pharm Inc Anti-Angiogene Mittel und Verfahren zu deren Verwendung
US20030203976A1 (en) 1993-07-19 2003-10-30 William L. Hunter Anti-angiogenic compositions and methods of use
AU728873B2 (en) * 1993-07-19 2001-01-18 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
AU771815B2 (en) * 1993-07-19 2004-04-01 Angiotech Pharmaceuticals, Inc. Anti-angiogenic compositions and methods of use
US6562596B1 (en) * 1993-10-06 2003-05-13 Amgen Inc. Tissue inhibitor of metalloproteinase type three (TIMP-3) composition and methods
US5837680A (en) * 1996-02-16 1998-11-17 Children's Medical Center Corporation Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis
US6495579B1 (en) 1996-12-02 2002-12-17 Angiotech Pharmaceuticals, Inc. Method for treating multiple sclerosis
US6515016B2 (en) 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis
US20040254635A1 (en) 1998-03-30 2004-12-16 Shanley John F. Expandable medical device for delivery of beneficial agent
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7208010B2 (en) 2000-10-16 2007-04-24 Conor Medsystems, Inc. Expandable medical device for delivery of beneficial agent
US6120847A (en) * 1999-01-08 2000-09-19 Scimed Life Systems, Inc. Surface treatment method for stent coating
US6419692B1 (en) 1999-02-03 2002-07-16 Scimed Life Systems, Inc. Surface protection method for stents and balloon catheters for drug delivery
US6156373A (en) 1999-05-03 2000-12-05 Scimed Life Systems, Inc. Medical device coating methods and devices
ATE467403T1 (de) 2000-10-16 2010-05-15 Conor Medsystems Inc Expandierbare medizinische vorrichtung zur freisetzung eines heilmittels
US20040073294A1 (en) 2002-09-20 2004-04-15 Conor Medsystems, Inc. Method and apparatus for loading a beneficial agent into an expandable medical device
AU2003252039A1 (en) * 2002-07-23 2004-02-09 Vegenics Limited Methods and compositions for activating or inhibiting vegf-d and vegf-c
WO2004087214A1 (en) 2003-03-28 2004-10-14 Conor Medsystems, Inc. Implantable medical device with beneficial agent concentration gradient
US7785653B2 (en) 2003-09-22 2010-08-31 Innovational Holdings Llc Method and apparatus for loading a beneficial agent into an expandable medical device
WO2014038866A1 (ko) * 2012-09-05 2014-03-13 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재
KR101539700B1 (ko) * 2012-09-05 2015-07-28 아주대학교산학협력단 연골세포 유래 세포외 기질막을 이용한 신생혈관질환 치료용 조성물 및 각막 또는 결막 이식재

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743587A (en) * 1985-09-10 1988-05-10 G. D. Searle & Co. Hydroxamic acid based collagenase inhibitors
US4766111A (en) * 1985-10-31 1988-08-23 Trustees Of Boston University Lipids with plasmin inhibitory properties
US5260059A (en) * 1989-04-14 1993-11-09 The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor

Also Published As

Publication number Publication date
CA2074725A1 (en) 1991-07-26
JPH06509791A (ja) 1994-11-02
AU7335191A (en) 1991-08-21
WO1991011193A1 (en) 1991-08-08
DE69122956T2 (de) 1997-05-22
ATE144710T1 (de) 1996-11-15
DE69122956D1 (de) 1996-12-05
DK0512071T3 (da) 1996-11-25
ES2093699T3 (es) 1997-01-01
EP0512071A4 (en) 1993-05-05
EP0512071A1 (en) 1992-11-11
AU652744B2 (en) 1994-09-08
EP0512071B1 (en) 1996-10-30

Similar Documents

Publication Publication Date Title
GR3021925T3 (en) Method and compositions for inhibiting angiogenesis
ATE556705T1 (de) Darreichungsform enthaltend taxol in kristalliner form
ATE278397T1 (de) Verwendung von cytoskelettinhibitoren zur vorbeugung der restenose
IL146311A0 (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
IL138973A0 (en) Compounds that inhibit the binding of integrins to their receptors
TR200102648T2 (tr) Büyümeyi destekleyen bileşimler
UA40578C2 (uk) Сульфоніламінопіримідини і фармацевтичний препарат на їх основі
IL146313A (en) Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
IL146312A (en) 3-(2-oxo-pyridinyl)-acylamino-propanoic acid derivatives that inhibit the binding of integrins to their receptors and pharmaceutical compositions comprising the same